News

UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.

NCLH's steep valuation discount faces a major test as falling earnings estimates, weak yields and high leverage cloud its recovery.

Dow Jones tech titan Alphabet is approaching a buy point, but there are key flaws. SK Hynix is another top stock to watch.

ANET is riding surging AI networking demand as Etherlink customers top 100 and diverse AI architectures expand its opportunity.

MCD's U.S. traffic weakness and execution issues weigh on the stock, but international growth, beverages and a recovery plan offer upside.

Datavault AI Inc. (NASDAQ: $DVLT) has agreed to acquire Wyoming-chartered BankWyse, adding regulated custody and co...

CCOI trades near a five-year-low sales valuation as margins improve, but leverage, refinancing costs and cash-flow dependence keep risks elevated.

EL beats fiscal fourth-quarter estimates as sales rise 6%, fueled by Skin Care and Fragrance growth and sharply higher operating income.

The gold price jumped and the GDX gold miner ETF surged on Treasury Secretary Scott Bessent's move to cap long-term bond yields, which fell.

Does Unity Software Inc. (U) have what it takes to be a top stock pick for momentum investors? Let's find out.

Lithium Americas Corp. (LAC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Enovix Corporation (ENVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BXP's stronger leasing and discounted valuation improve its setup, but uneven rents, development costs and refinancing risks temper the upside.

Cogent Communications' 14% weekly rebound follows a narrower Q2 loss and margin gains, but revenue declines, Sprint runoff and debt risks keep the setup mixed.

CEO Gary Evans said the board concluded that the stock was undervalued after reviewing the company’s projects across the U.S., Canada and Mexico.

Bitcoin broke out of a months long trading range, surging as much as 7.7%, amid optimism on the regulatory front with industry officials gathering at the White House.

Small-cap investors have been disappointed for years. Here's why that trend might finally be ready to reverse.

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.

Coinbase Global Inc (NASDAQ:COIN) stock is moving higher Wednesday as the broader cryptocurrency market finds its footing. Coinbase Global shares are climbing with conviction. Why is COIN stock surging? Bitcoin Stabilization Fuels Optimism Bitcoin (CRYPTO: BTC) is climbing near the $68,500-level after weathering recent selling pressure, supported by ETFs pulling in $486.85 million across the first two sessions of the week. A climbing Bitcoin price ignites retail and institutional trading activit

Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by regulators. Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors. In current studies, they are pairing it with Keytruda, a immunotherapy drug made by Merck.

All three major US stock indexes were up in late-morning trading Wednesday, after the Treasury Depar

ABM's ELEVATE strategy, data center and AI investments, acquisitions and strong liquidity support growth despite rising costs and intense competition.

TOL beats Q3 earnings and revenue estimates as higher home prices offset fewer deliveries, while orders grow despite margin pressure.

Oil-price volatility is shaking markets, but Plexus, Twilio and MACOM stand out as momentum stocks with strong one-year gains and recent pullbacks.

Intel Intel (NASDAQ:INTC) CEO Lip-Bu Tan bought about $10 million worth of INTC shares earlier this month at $95 a share, the same price at which Intel had just priced a $20 billion secondary offering days earlier. Intel’s Q2 revenue rose 25% year over year, a massive acceleration from Q1’s 7% growth. Margins jumped to […]

TGT tops Q2 estimates as traffic, digital and category sales strengthen, while tariff refunds lift profitability, and management raises its fiscal 2026 outlook.

Jack Henry's Q4 revenues rise 4.7% on processing, cloud hosting and faster payment growth, while higher personnel costs pressure margins.

It's rare for any company to be able to remain in a position to dominate its markets. This one is a compelling exception.

The partnership deepens Marvell's role in custom AI silicon.

KEYS delivered a strong fiscal Q3, with revenues and earnings beating estimates, supported by demand for AI infrastructure and connectivity.